{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:32:44Z","timestamp":1793223164082,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR073233"],"award-info":[{"award-number":["AR073233"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jbc.2026.113524","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"page":"113524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["B1486 is a highly potent VprBP inhibitor capable of blocking osteoclast differentiation and bone resorption"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-6430","authenticated-orcid":false,"given":"Sungmin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4447-3737","authenticated-orcid":false,"given":"Nikhil B.","family":"Ghate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8756-595X","authenticated-orcid":false,"given":"Woojin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113524_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-1119(00)00583-7","article-title":"Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP","volume":"263","author":"Zhang","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.jbc.2026.113524_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4690-2-11","article-title":"The Vpr protein from HIV-1: distinct roles along the viral life cycle","volume":"2","author":"Le Rouzic","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.jbc.2026.113524_bib3","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/onc.2008.44","article-title":"VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation","volume":"27","author":"Huang","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113524_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd6078","article-title":"CRL4(DCAF1\/VprBP) E3 ubiquitin ligase controls ribosome biogenesis, cell proliferation, and development","volume":"6","author":"Han","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2026.113524_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4161\/cc.6.2.3732","article-title":"HIV1 Vpr arrests the cell cycle by recruiting DCAF1\/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase","volume":"6","author":"Le Rouzic","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2026.113524_bib6","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1128\/MCB.00232-08","article-title":"Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development","volume":"28","author":"McCall","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113524_bib7","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1073\/pnas.0702102104","article-title":"Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle","volume":"104","author":"Hrecka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.jbc.2026.113524_bib8","doi-asserted-by":"crossref","first-page":"27046","DOI":"10.1074\/jbc.M703955200","article-title":"The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP\/DCAF1 as an adaptor","volume":"282","author":"Wen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113524_bib9","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1128\/JVI.01380-07","article-title":"DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest","volume":"81","author":"Tan","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jbc.2026.113524_bib10","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1073\/pnas.0610167104","article-title":"HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1","volume":"104","author":"Schrofelbauer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113524_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.molcel.2013.09.017","article-title":"VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription","volume":"52","author":"Kim","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.113524_bib12","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1002\/1878-0261.13068","article-title":"VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer","volume":"15","author":"Ghate","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jbc.2026.113524_bib13","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.3390\/biomedicines11092552","article-title":"VprBP\/DCAF1 triggers melanomagenic gene silencing through histone H2A phosphorylation","volume":"11","author":"Shin","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2026.113524_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/jmcb\/mjy085","article-title":"DCAF1 (VprBP): emerging physiological roles for a unique dual-service E3 ubiquitin ligase substrate receptor","volume":"11","author":"Schabla","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113524_bib15","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/s41467-023-37883-1","article-title":"Phosphorylation and stabilization of EZH2 by DCAF1\/VprBP trigger aberrant gene silencing in colon cancer","volume":"14","author":"Ghate","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113524_bib16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/s41388-023-02685-8","article-title":"VprBP\/DCAF1 regulates p53 function and stability through site-specific phosphorylation","volume":"42","author":"Ghate","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113524_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13072-024-00561-7","article-title":"VprBP regulates osteoclast differentiation via an epigenetic mechanism involving histone H2A phosphorylation","volume":"17","author":"Shin","year":"2024","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jbc.2026.113524_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/minf.201200141","article-title":"Chemically Advanced Template Search (CATS) for scaffold-hopping and prospective target prediction for 'Orphan' molecules","volume":"32","author":"Reutlinger","year":"2013","journal-title":"Mol. Inform"},{"key":"10.1016\/j.jbc.2026.113524_bib19","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F","article-title":"\"Scaffold-Hopping\" by topological pharmacophore search: a contribution to virtual screening","volume":"38","author":"Schneider","year":"1999","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.113524_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1101\/gad.268714.115","article-title":"MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis","volume":"30","author":"Kim","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.113524_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13072-018-0193-1","article-title":"H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis","volume":"11","author":"Kim","year":"2018","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jbc.2026.113524_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13072-019-0270-0","article-title":"DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis","volume":"12","author":"Shin","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jbc.2026.113524_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41388-021-02109-5","article-title":"MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis","volume":"41","author":"Shin","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113524_bib24","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1128\/MCB.20.9.3058-3068.2000","article-title":"SWI-SNF-mediated nucleosome remodeling: role of histone octamer mobility in the persistence of the remodeled state","volume":"20","author":"Jaskelioff","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113524_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0076-6879(03)75002-2","article-title":"Reconstitution of nucleosome core particles from recombinant histones and DNA","volume":"375","author":"Dyer","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jbc.2026.113524_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/MCB.06037-11","article-title":"Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail","volume":"32","author":"Kim","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113524_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molcel.2008.02.029","article-title":"FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16","volume":"30","author":"Heo","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.113524_bib28","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1074\/jbc.M708205200","article-title":"Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription","volume":"283","author":"Kim","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113524_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jbmr.4256","article-title":"Skeletal biology and disease modeling in zebrafish","volume":"36","author":"Dietrich","year":"2021","journal-title":"J. Bone Miner Res."},{"key":"10.1016\/j.jbc.2026.113524_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/dbio.2001.0390","article-title":"Visualizing normal and defective bone development in zebrafish embryos using the fluorescent chromophore calcein","volume":"238","author":"Du","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jbc.2026.113524_bib31","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3390\/molecules22122068","article-title":"Live fluorescent staining platform for drug-screening and mechanism-analysis in zebrafish for bone mineralization","volume":"22","author":"Chen","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2026.113524_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.celrep.2018.06.020","article-title":"Regulation of breast cancer-induced osteoclastogenesis by MacroH2A1.2 involving EZH2-Mediated H3K27me3","volume":"24","author":"Kim","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.113524_bib33","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1038\/s41388-018-0356-3","article-title":"MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1alpha and H1.2","volume":"37","author":"Kim","year":"2018","journal-title":"Oncogene"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826023963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826023963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:40:17Z","timestamp":1793220017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826023963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0021925826023963"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113524","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B1486 is a highly potent VprBP inhibitor capable of blocking osteoclast differentiation and bone resorption","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113524"}}